Logo-jcvtr
Submitted: 24 Aug 2022
Revision: 25 Dec 2022
Accepted: 28 Dec 2022
ePublished: 16 Mar 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Cardiovasc Thorac Res. 2023;15(1): 14-21.
doi: 10.34172/jcvtr.2023.31627
PMID: 37342660
PMCID: PMC10278190
  Abstract View: 781
  PDF Download: 536
  Full Text View: 141

Original Article

The association of serum uric acid/albumin ratio with the development of coronary collateral circulation in patients with chronic total occluded coronary arteries

Faysal Şaylık 1* ORCID logo, Tufan Çınar 2, Remzi Sarıkaya 1, Tayyar Akbulut 1, Murat Selçuk 2, Emrah Özbek 1, Halil İbrahim Tanboğa 3

1 Department of Cardiology, Van Education and Research Hospital, Van, Turkey
2 Department of Cardiology, Sultan Abdulhamid Han Education and Research Hospital, Istanbul, Turkey
3 Department of Cardiology and Biostatistics, Istanbul Nisantasi University, Istanbul, Turkey
*Corresponding Author: Corresponding Author: Faysal Saylik, Email: , Email: faysalsaylik@gmail.com

Abstract

Introduction: Coronary collateral circulation (CCC) develops in chronic total occluded (CTO) vessels and protects the myocardium against ischemia in addition to the improvement of cardiac functions. Poor CCC is related to adverse cardiac events as well as poor prognosis. Serum uric acid/albumin ratio (UAR) has emerged as a novel marker associated with poor cardiovascular outcomes. We aimed to investigate whether there was an association between UAR and poor CCC in CTO patients.

Methods: This study was comprised of 212 patients with CTO (92 with poor CCC and 120 with good CCC). All patients were graded based on Rentrop scores to poor CCC (Rentrop scores 0 and 1) and good CCC (Rentrop scores 2 and 3).

Results: Poor CCC patients had higher frequencies of diabetes mellitus, triglyceride levels, Syntax and Gensini scores, uric acid, and UAR and lower lymphocyte, high-density lipoprotein cholesterol, and ejection fraction when compared to good CCC patients. UAR was an independent predictor of poor CCC in CTO patients. Furthermore, UAR had a better discriminative ability for patients with poor CCC from good CCC compared to serum uric acid and albumin.

Conclusion: Based on the results of the study, the UAR could be used to detect poor CCC in CTO patients.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 782

Your browser does not support the canvas element.


PDF Download: 536

Your browser does not support the canvas element.


Full Text View: 141

Your browser does not support the canvas element.